AduhelmActive Ingredient(s): Aducanumab-avwa
FDA Approved: * June 7, 2021
Pharm Company: * BIOGEN INC
Category: Alzheimers / Dementia
Aducanumab, sold under the brand name Aduhelm, is a medication designed to treat Alzheimer's disease (AD). It is an amyloid beta-directed monoclonal antibody that targets aggregated forms of amyloid beta (Aβ) found in the brains of people with Alzheimer's disease to reduce its buildup. Aducanumab was approved for medical use in the United States by the Food and Drug Administr... [wikipedia]* May have multiple approval dates, manufacturers, or labelers.